Skip to content

Different approaches to nerve block can affect intraoperative visual clarity and postoperative enhanced recovery after arthroscopic rotator cuff repair: a prospective, triple-blind, randomized controlled trial

Different approaches to nerve block can affect intraoperative visual clarity and postoperative enhanced recovery after arthroscopic rotator cuff repair: a prospective, triple-blind, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112476
Enrollment
Unknown
Registered
2025-11-14
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff injury

Interventions

A:Receive interscalene brachial plexus block (ISB) combined with general anesthesia preoperatively
B:Receive supraclavicular brachial plexus block (SCB) combined with general anesthesia preoperatively
C:Receive suprascapular nerve block (SNB) combined with general anesthesia preoperatively

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients who undergo arthroscopic double-row suture anchor rotator cuff repair for full-thickness rotator cuff tears (2) Aged 18–65 years (3) Normal platelet count and coagulation function (4) No invasive procedures performed on the affected shoulder joint within 3 months before surgery (5) ASA (American Society of Anesthesiologists) physical status classification: Grade 1–2 (6) Subjects and their family members have been informed of the nature of the study, understood the study regulations, have good compliance, and signed the informed consent form

Exclusion criteria

Exclusion criteria: (1) Patients who refuse to participate in this study (2) Patients with anesthesia-related contraindications (3) Poorly controlled hypertension (systolic blood pressure > 180 mmHg or diastolic blood pressure > 110 mmHg) (4) Patients with mental disorders or poor compliance (5) Patients with severe organ diseases that preclude surgery, such as severe hepatic or renal insufficiency, severe cardio-cerebrovascular diseases, coagulation disorders, or abnormal platelet counts (6) Patients with hemorrhagic diseases (7) Patients requiring long-term use of anticoagulant or antiplatelet drugs due to medical conditions (8) Patients requiring long-term use of analgesic drugs (9) ASA physical status classification > Grade 2 (10) Diabetic patients with poorly controlled blood glucose (11) Special populations such as pregnant women (12) Patients who underwent invasive procedures on the affected shoulder within 3 months before surgery (13) Patients allergic to the drugs to be used in the study (14) Patients with other types of shoulder joint diseases, such as massive rotator cuff tears, Hill-Sachs lesions, Bankart lesions, calcific tendinitis, or frozen shoulder

Design outcomes

Primary

MeasureTime frame
Intraoperative arthroscopic visualization clarity;

Secondary

MeasureTime frame
Intraoperative mean blood pressure;Intraoperative mean heart rate ;Surgical duration;Intraoperative irrigation fluid volume;Postoperative irrigation fluid red blood cell count;Inflammatory marker levels;Hemoglobin level;VAS score;Shoulder joint swelling degree;Time to first use of tramadol within 24 hours postoperatively;Intraoperative dosage of hypotensive drugs;

Countries

China

Contacts

Public ContactLihan Shi

Hospital of Chengdu University of Traditional Chinese Medicine

shilihan1989@sina.com+86 176 1280 8930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026